SCHEMBL8761111

SCHEMBL8761111

[O][CH]c1conn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL28291711 0.68 P2RX7 (0.38)
SCHEMBL1231009 0.63
SCHEMBL27488323 0.62
SCHEMBL1058399 0.60
SCHEMBL1058397 0.60
SCHEMBL486333 0.59
SCHEMBL4633790 0.59
SCHEMBL1006955 0.59
SCHEMBL4633794 0.59
SCHEMBL12473381 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0590415-B1 1,2,4-Oxadiazole derivatives for controlling endoparasites BAYER AG (DE) 1997-06-04 EP claimed
US-5428047-A Nematocides BAYER AKTIENGESELLSCHAFT (DE) 1995-06-27 US claimed
EP-0590415-A2 1,2,4-Oxadiazole derivatives for controlling endoparasites BAYER AG (DE) 1994-04-06 EP claimed
EP-0590415-B1 1,2,4-Oxadiazole derivatives for controlling endoparasites BAYER AG (DE) 1997-06-04 EP disclosed
US-5428047-A Nematocides BAYER AKTIENGESELLSCHAFT (DE) 1995-06-27 US disclosed
EP-0590415-A2 1,2,4-Oxadiazole derivatives for controlling endoparasites BAYER AG (DE) 1994-04-06 EP disclosed